Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

PowerPoint Presentation
Nikhitha Chandrashekar, MD et al., UW Health, Madison, WI View Poster
Waterbirth_Kamps-Schmitt_Updated 4-30-20 ENDOCRINOPATHIES ASSOCIATED WITH IBRUTINIB – A RETROSPECTIVE ANALYSIS Nikhitha Chandrashekar, MD; Julia Shariff, MD; Daniel Short, MD, PhD, FACP, FACE INTRODUCTION CONCLUSIONS RESULTS ➢ Tyrosine Kinase Inhibitors (TKI) are used to for the targeted treatment of hematologic malignancies ➢ FDA approved indications for ibrutinib have been …
November 10, 2020
The APMC focuses primarily on providing education about APMs and other value-based care programs in cancer care.
1 ACCC Research Review: November 2020 Training for the Clinical Trials Workforce: A Message from the President's Task Force By Al B. Benson III, MD, FACP, FASCO This edition of the ACCC Research Review focuses on issues related to workforce training for cancer clinical research. Whether a cancer program is currently conducting clinical studies or is considering becoming a trial …
CCMED_7_10_Infographic_Oct_14_2020 Improving Non-Small Cell Lung Cancer Care Delivery: Learnings for Oncology Nurses and Patient Navigation From a National Quality Survey Aversano et al. (2020) How Patient Navigation Models in Non-Small Cell Lung Cancer Care Programs in the US Can Be Improved BREAST CANCER PROGRAM NAME SUPPORTING TEXT CAN GO HERE, MORE SUPPORT TEXT …
Improving Non-Small Cell Lung Cancer Care Delivery: Findings for Oncology Nurses and Patient Navigation From a National Quality Survey Jennifer Aversano, MSN, RN, OCN, BMTCN1; Leigh M. Boehmer, PharmD, BCOP2; Alexander Spira, MD, PhD, FACP3,4,5 1Advocate Lutheran General Hospital, Park Ridge, Illinois, USA; 2Association of Community Cancer Centers, Rockville, Maryland, USA; 3Virginia Cancer …
CCMED_8_9_Infographic_Draft1_Sep_14_2020 accc-cancer.org/NSCLC-thoracic Optimizing Care Coordination for Patients with Stage III/IV NSCLC: Learnings from the ACCC National Quality Survey for Thoracic Surgeons, Radiation Oncologists and Medical Oncologists Stiles et al. (2020) This survey highlights discrepancies and gaps in the knowledge of and challenges faced by thoracic …
Presented at AONN+ Annual Conference; November 4- November 8.
November 6, 2020
Lauren Hamel, PhD, Assistant Professor, Wayne State University/Karmanos Cancer Institute David W. Dougherty, MD, MBA, Medical Director, DFCI Network, Dana-Farber Cancer Institute Angie Santiago, CRCS, Lead Financial Counselor, Oncology, Sidney Kimmel Cancer Center (Moderator)) Given that up to half of all patients with cancer experience financial toxicity, and that some patients even forego treatment …
Poster Title Goes Here Poster Title Goes Here Poster Title Goes Here Poster Title Goes Here Poster Title Goes Here Poster Title Salicylates Potentiate and Broaden CRM1 Inhibitor Anti-Tumor Activity via S- Phase Arrest and Impaired DNA-Damage Repair Jithma P. Abeykoon1, Xiaosheng Wu1, Kevin E. Nowakowski1, Surendra Dasari2, Jonas Paludo1, S. John Weroha3, Chunling Hu4, Jann N. …
Poster Title Goes Here Poster Title Goes Here Poster Title Goes Here Poster Title Goes Here Title Goes Here Poster Title Goes Here Poster Title Goes Here Poster Title Goes Here Investigating the Roles of Bim and CX3CR1/Granzyme B in Predicting Response to PD-1 Blockade Therapy Background: Immunotherapy targeting immune checkpoints has become a common approach for many types …
MSCO20_KANKEU FONKOUA.pptx Enhanced efficacy of anti-VEGFR2/taxane therapy after progression on immune checkpoint inhibition (ICI) in patients with metastatic gastroesophageal adenocarcinoma (mGEA). Lionel Kankeu Fonkoua 1, Sakti Chakrabarti 1, Mohamad B. Sonbol 2, Pashtoon M. Kasi 3, Jason S. Starr 3, Alex J. Liu 2, Melanie C. Bois 4, Henry C. Pitot 1, Chandrikha Chandrasekharan …
Slide 1 • Figure 1: Serum sPD-L1 levels were measured in a retrospective cohort of patients with melanoma. In a multivariate Cox proportional hazards analysis, high sPD-L1 prior to treatment predicted worse survival (HR 1.49; 95% CI 1.06-2.09; p=0.025) when accounting for advanced age (not significant), sex (not significant), late stage (p=0.002) and high …
November 4, 2020
Expert faculty will Identify new emerging therapies in the care for multiple myeloma patients and provide examples of how to operationalize care of this patient population.
OI | November–December 2020 | accc-cancer.org 47 First Person Perspective BY CHRISTIE MANGIR Being diagnosed with breast cancer at age 30 and learning I needed che- motherapy was devastating. I did not feel like I had a choice. If I wanted to live, I had to complete an intense regimen of chemotherapies and tar- geted therapies. Cancer patients do not have many choices, but one of the …
A supportive care option to prevent hair loss for women—and men—undergoing chemotherapy.
Due to the COVID-19 pandemic and its associated risks for patients with cancer, all Life with Cancer programming was cancelled on Mar. 12, 2020. Staff, struggling with their own anxiety over personal safety, quickly went into action on how best to continue to meet the psychological and educational needs of patients and families.
Since the approval of the programmed death-1 (PD-1) inhibitors pembrolizumab and nivolumab for the treatment of metastatic melanoma in 2014, the oncology community has seen a tidal wave of new approvals and indications for immunotherapies to treat cancer.
On Oct. 5, ACCC provided comments to the Centers for Medicare & Medicaid Services (CMS) on the agency’s proposed CY 2021 Outpatient Prospective Payment System (OPPS) and Physician Fee Schedule (PFS) rules.